Djibouti vs Paraguay: Cause of death, by non-communicable diseases, female
Djibouti
49.6%
in 2021
Paraguay
52.0%
in 2021
Djibouti rank
142nd
Paraguay rank
139th
Cause of death, by non-communicable diseases, female over time
- Djibouti
- Paraguay
How they compare
Paraguay currently reports 52.0% against 49.6% in Djibouti, a difference of 2.4%.
Across all 6 years both countries report, Paraguay has been ahead every year.
Djibouti ranks 142nd and Paraguay ranks 139th of 185 countries.
Paraguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 31.5% | 65.8% | 34.4% | Paraguay |
| 2010s | 46.6% | 77.3% | 30.7% | Paraguay |
| 2020s | 50.7% | 62.6% | 11.9% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Djibouti or Paraguay?
- Paraguay, at 52.0% against 49.6% in Djibouti as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Djibouti and Paraguay?
- 2.4%, with Paraguay ahead.
- How many years of comparable data are there for Djibouti and Paraguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Djibouti and Paraguay rank globally for cause of death, by non-communicable diseases, female?
- Djibouti ranks 142nd and Paraguay ranks 139th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.